Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025 financial guidance announcement
Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb.
Eli Lilly & Co: Buy Rating Backed by Promising Orfoglipron Trials and Strong Pharmaceutical Pipeline
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Hosted on MSN20h
Butler intends to honor Clowes' history during expansion
Butler University's plans to renovate and expand Clowes Memorial Hall, including the addition of a ballroom space, aim to ...
Eli Lilly & Co’s Promising Growth: Accelerated Revenue and Drug Pipeline Advances
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...
Sports Business Journal3h
NBA Paris Games draws partners for Wemby return
NBA Paris Games are drawing out a mass of fans and league/team partners to Paris to watch Victor Wembanyama's homecoming.
Sports Business Journal5h
NBA Paris Games draws fans, partners for Wembanyama's homecoming
NBA Paris Games are drawing out a mass of fans and league/team partners to Paris to watch Victor Wembanyama's homecoming.
Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
Purdue Pharma and owners to pay $7.4B in settlement over OxyContin’s toll
The deal represents an increase of more than $1 billion over a previous settlement deal that was rejected last year by the ...
NBC Sports16h
Rumor Mill
One of the talking points after last Saturday’s Chiefs win over the Texans was tight end Travis Kelce’s vintage performance. Kelce had seven catches for 117 yards and a touchdown in the 23-14 win, so ...